Genes that are associated with the occurrence of breast cancer in women, also trigger prostate cancer in men

Defective genes that are closely associated with the occurrence of breast cancer, are also responsible for the emergence of a dangerous form of prostate cancer, the researchers said. Scientists from the University of Toronto (Canada) found that carriers of the BRCA2 gene on average four years lived after he was diagnosed with prostate cancer. Although the average men live with this diagnosis 12 years. The study was published in the British Journal of Cancer. Every year in the UK around 35 thousand men with prostate cancer diagnosed and about 10 thousand die from the disease. This study involved 301 volunteers. The study was conducted. On the defective BRCA1 and BRCA2 genes, which are aligned with an increased risk of breast and ovarian cancer in women Scientists have found that the presence of two genes also shortens the life of the people. On average, living carriers of the BRCA1 gene in prostate cancer about 8 years. BRCA2 gene was much more dangerous, if at all, and prostate cancer in men lived an average of about two years. According to experts, it is important to detect the disease at an early stage, it will maximize the lifetime of the patient.